联康生物科技集团有限公司（股票代码：00690）于2026年6月3日披露2026年5月股份变动月报表。报告期内，公司法定注册股本维持在500,000,000,000股普通股，面值每股港币0.01，合计港币50亿元。公司已发行普通股5,971,228,147股，与上月底持平，库藏股数目保持为零。
公司现有2016年股份期权计划合计420,589,000份股份期权，本月并无行权或转让交易，期权数量及股本结构保持稳定。截至2026年5月底，公司已满足香港联交所上市规则的公众持股量要求，所有相关发行与处置均遵守适用的法律法规。
该公告由公司秘书何咏欣女士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.